AKT1 and benign prostatic hyperplasia: Therefore, bioinformatics results from transcriptome sequencing suggest that avellanin A may inhibit the expression of extracellular matrix integrins, collagen, and matrix metalloproteinases, thereby inhibiting the expression of the downstream PI3K-Akt signalling pathway and thereby inhibiting the progression of TP-induced BPH.